Arthur Kavanaugh, MD
Ophthalmology · Shreveport, LANPI 1366653016
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 53.0% of the total. Reporting peaked in 2019 at $4,150 and has fallen 79.1% since, to $866 in 2025.
Across 92 payments — averaging $75.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$4K
- AbbVie$780
- Alcon$742
- Regeneron Healthcare Solutions, Inc.$359
- Apellis Pharmaceuticals, Inc.$290
- Dompe US, Inc.$258
- plus $845 from 9 others
What the payments were for
- Consulting fees$3,69053%
- Food & beverage$3,27447%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 2 | $3,690 |
| AbbVie(2 entities) | 33 | $780 |
| Alcon | 9 | $742 |
| Regeneron Healthcare Solutions, Inc. | 13 | $359 |
| Apellis Pharmaceuticals, Inc. | 7 | $290 |
| Dompe US, Inc. | 2 | $258 |
| Alimera Sciences, Inc. | 6 | $214 |
| Glaukos Corporation | 2 | $176 |
| Bausch & Lomb Americas Inc. | 6 | $139 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $100 |
| Amgen(2 entities) | 4 | $80 |
| Astellas Pharma US Inc | 3 | $51 |
| Mallinckrodt Hospital Products Inc. | 2 | $49 |
| Genentech USA, Inc. | 1 | $22 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oxervate$258
- Centurion$248
- Tecnis IOL$200
- iStent inject Trabecular Micro-Bypass Stent System$156
- Photrexa$156
- Hydrus Microstent$134
- Voyager DSLT$134
- ReSTOR$127
- EYLEA$125
- Iluvien$125
- Syfovre$125
- DURYSTA$118
- AcrySof IQ VIVITY IOL$105
How this compares
$6,964 in reported general payments places this provider in the 85th percentile of 286 ophthalmology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 13 | $5,726 |
| Prednisolone Acetate | 93 | $4,948 |
| Atropine Sulfate | 26 | $1,433 |
| Latanoprost | 99 | $896 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 52 | $781 |
| Dorzolamide Hcl | 28 | $342 |
| MoxifloxacinMoxifloxacin Hcl | 16 | $317 |
| Timolol Maleate | 26 | $246 |
| Brimonidine Tartrate | 31 | $207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan | $780 | $5,72613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 286 ophthalmology providers in Louisiana.
Other ophthalmology in Shreveport
- Wyche ColemanShreveport$35K
- Bryan VekoviusShreveport$29K
- Christopher ShelbyShreveport$27K
- Chanping LiangShreveport$15K
- Claude BundrickShreveport$12K
- Bryan LuskShreveport$10K
- Ann GuyShreveport$6K
- Jeffrey LuskShreveport$5K
- John CarmodyShreveport$5K
- Blake WilliamsonBaton Rouge$443K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.